Atreca Inc Valuation

BCELDelisted Stock  USD 0.07  0.0005  0.70%   
Atreca seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Atreca Inc from analyzing the firm fundamentals such as Return On Equity of -1.83, current valuation of (17.08 M), and Shares Owned By Insiders of 2.73 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor picking up undervalued instruments and discarding overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
0.07
Please note that Atreca's price fluctuation is out of control at this time. Calculation of the real value of Atreca Inc is based on 3 months time horizon. Increasing Atreca's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Atreca Inc is useful when determining the fair value of the Atreca pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Atreca. Since Atreca is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Atreca Pink Sheet. However, Atreca's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.071 Real  0.0675 Hype  0.07 Naive  0.0145
The real value of Atreca Pink Sheet, also known as its intrinsic value, is the underlying worth of Atreca Inc Company, which is reflected in its stock price. It is based on Atreca's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Atreca's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Atreca's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.07
Real Value
12.57
Upside
Estimating the potential upside or downside of Atreca Inc helps investors to forecast how Atreca pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Atreca more accurately as focusing exclusively on Atreca's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.140.26
Details
Hype
Prediction
LowEstimatedHigh
0.000.0712.57
Details
Naive
Forecast
LowNext ValueHigh
0.00030.0112.52
Details

Atreca Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Atreca's current stock value. Our valuation model uses many indicators to compare Atreca value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atreca competition to find correlations between indicators driving Atreca's intrinsic value. More Info.
Atreca Inc is rated second in price to earning category among related companies. It is rated below average in price to book category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Atreca by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Atreca's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Atreca's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Atreca's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Atreca and how it compares across the competition.

About Atreca Valuation

The pink sheet valuation mechanism determines the current worth of Atreca Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Atreca Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Atreca Inc based exclusively on its fundamental and basic technical indicators. By analyzing Atreca's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Atreca's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Atreca. We calculate exposure to Atreca's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Atreca's related companies.
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.

8 Steps to conduct Atreca's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Atreca's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Atreca's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Atreca's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Atreca's revenue streams: Identify Atreca's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Atreca's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Atreca's growth potential: Evaluate Atreca's management, business model, and growth potential.
  • Determine Atreca's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Atreca's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Atreca Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Atreca does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding38.6 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Note that the Atreca Inc information on this page should be used as a complementary analysis to other Atreca's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Atreca Pink Sheet

If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas